Related Experiment Video
Updated: May 5, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Medication-assisted treatment with methadone: assessing the evidence
Objective:
Detoxification followed by abstinence has shown little success in reducing illicit opioid use. Methadone maintenance treatment (MMT) helps individuals with an opioid use disorder abstain from or decrease use of illegal or nonmedical opiates. This review examined evidence for MMT's effectiveness.
Methods:
Authors reviewed meta-analyses, systematic reviews, and individual studies of MMT from 1995 through 2012. Databases searched were PubMed, PsycINFO, Applied Social Sciences Index and Abstracts, Sociological Abstracts, Social Services Abstracts, and Published International Literature on Traumatic Stress. The authors rated the level of evidence (high, moderate, and low) based on benchmarks for the number of studies and quality of their methodology. They also described the evidence of service effectiveness and examined maternal and fetal results of MMT for pregnant women.
Results:
The review included seven randomized controlled trials and two quasi-experimental studies of MMT, indicating a high level of evidence for the positive impact of MMT on treatment retention and illicit opioid use, particularly at doses greater than 60 mg. Evidence suggests positive impacts on drug-related HIV risk behaviors, mortality, and criminality. Meta-analyses were difficult to perform or yielded nonsignificant results. Studies found little association between MMT and sex-related HIV risk behaviors. MMT in pregnancy was associated with improved maternal and fetal outcomes, and rates of neonatal abstinence syndrome were similar for mothers receiving different doses. Reports of adverse events were also found.
Conclusions:
MMT is associated with improved outcomes for individuals and pregnant women with opioid use disorders. MMT should be a covered service available to all individuals.
Insights
Methadone maintenance treatment (MMT) significantly reduces illicit opioid use and improves treatment retention for individuals with opioid use disorder. MMT also benefits pregnant women and their infants, supporting its universal availability.
Area of Science:
- Addiction Medicine
- Public Health
- Pharmacology
Background:
- Detoxification and abstinence have limited success in reducing illicit opioid use.
- Opioid use disorder (OUD) is a significant public health challenge requiring effective treatment.
- Methadone maintenance treatment (MMT) is a cornerstone therapy for OUD.
Purpose of the Study:
- To review and synthesize evidence on the effectiveness of Methadone Maintenance Treatment (MMT).
- To examine MMT's impact on illicit opioid use, treatment retention, and associated risks.
- To evaluate MMT outcomes in pregnant women and their infants.
Main Methods:
- Systematic review of meta-analyses, systematic reviews, and randomized controlled trials (RCTs) from 1995-2012.
- Searched multiple databases including PubMed, PsycINFO, and relevant social science indexes.
- Evidence levels were rated (high, moderate, low) based on study quality and quantity.
Main Results:
- High evidence supports MMT's positive impact on treatment retention and reduced illicit opioid use, especially at doses >60 mg.
- MMT is associated with improved outcomes in drug-related HIV risk behaviors, mortality, and criminality.
- MMT in pregnancy demonstrated improved maternal and fetal outcomes with comparable neonatal abstinence syndrome rates across doses.
Conclusions:
- Methadone maintenance treatment is an effective intervention for individuals with opioid use disorder.
- MMT offers significant benefits for pregnant women and their infants.
- MMT should be a universally accessible and covered treatment service.
More Related Videos
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Dependence
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drug Therapy
Antianxiety Medications
Therapeutic Drug Monitoring: Drug Analysis Methods